Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

MDxHealth SA

MDXH ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: BUY

Last Close

$0.81

▲ +74.89%

Market Cap $77.10M · Vol 10.46M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$77.10M

Micro Cap

Div Yield

N/A

EPS Growth

+10.82%

YoY

RSI (14)

87.26

Momentum

Beta

1.00

vs Market

52W High

$5.33

84.84% below

52W Low

$0.40

102.00% above

Volume

10.46M

Avg 418.25K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

94.01%

Public shares

Shariah Compliance8 STANDARDS

✗ MDxHealth SA (MDXH) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MDXH pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+75.27%

+94.65%

-17.94%

-76.24%

YTD

-77.37%

-71.55%

-78.16%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$107.88M
Net Income	$-33,519,000.00
Revenue Growth (YoY)	+18.57%
Gross Margin	64.55%
Operating Margin	-13.36%
Net Profit Margin	-31.07%
ROE	N/A
ROA · ROIC	-23.18% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.65
P/B	N/A
P/FCF	N/A
EPS Growth	+10.82%
Outstanding Shares	95.42M

Technical Indicators

50-Day SMA	$0.48
200-Day SMA	$2.37
RSI (14)	87.26
Beta	1.00
52-Week High	$5.33
52-Week Low	$0.40

Volume Today	10.46M
Avg Daily Volume (30D)	418.25K
Relative Volume	25.01x
Volatility (10D)	267.11
Volatility (30D)	169.83
Free Float	94.01%

Analyst Consensus

BUY

Current Price $0.81

Mean Target $2.20

52W Low$0.40 52W High$5.33

Current

Target

$0.40 $5.33

Current Analyst target

+172.28% upside potential · 6 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SF8932

ISINBE0974461940

CountryBelgium

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.